Experts from the National Ebola Training and Education Center urge healthcare systems to adopt processes in line with “Identify, Isolate, and Inform,” a process for quickly identifying and managing cases of infectious disease in a way that minimizes the risk for subsequent transmissions.
In a scientific/public health triumph, the first vaccine for the prevention of Ebola virus infection has been approved. If administered prior to 10 days after exposure, its protective efficacy is 100%.
In addition to issues of malaria, vaccination, and trauma in travelers, viral diseases and the management of diarrhea were key topics at the biannual meeting of the International Society of Travel Medicine in Barcelona, Spain, during May 2017.
As this issue went to press, the CDC confirmed that a patient admitted to Emory University Hospital’s Serious Communicable Diseases Unit has Lassa fever, a hemorrhagic virus endemic in parts of West Africa.